The highly competitive global pharmaceutical market, patent expiries represent a critical turning point for companies, with the potential to significantly impact their revenue streams. As patents for blockbuster drugs approach expiration, the market opens up to generic competitors, which can cause a substantial drop in the pricing and market share of original branded products. Understanding this dynamic is essential for pharmaceutical companies to navigate the shifting landscape and maintain their competitive edge.
The global pharmaceutical industry faces a wave of patent expiries, with $260 billion worth of drug sales expected to lose exclusivity between 2023 and 2025. Drugs such as Eliquis, Revlimid, and Enbrel are set to face generic competition, potentially losing up to $40 billion annually in combined revenues. This massive shift underlines the growing importance of proactive pharma patent landscape analysis to help companies forecast risks and capitalize on opportunities in the face of patent expirations.
Pharma patent landscape analysis plays a pivotal role in competitive intelligence, allowing companies to anticipate patent expiries, evaluate potential threats from generics, and strategically position their portfolios. By analyzing patent expiries and their impact, businesses can better plan for product life-cycle management, regulatory strategies, and R&D investments to mitigate the financial risks associated with these market changes.
How Competitive Intelligence Helps Navigate Patent Expiry Risks?
Competitive intelligence helps navigate patent expiry risks by analyzing patent landscapes, identifying upcoming generics, assessing market shifts, and informing strategic decisions on product life-cycle management, R&D investments, and competitive positioning:
-
Identifying Patent Expiry Trends
Analyzing patent expiry dates and trends to forecast potential revenue losses and prepare for generic competition in advance.
-
Assessing Competitive Threats from Generics
Monitoring emerging generic competitors to understand their market entry strategies and their impact on branded drug sales.
-
Market Share Forecasting and Impact Analysis
Estimating the impact of patent expiries on market share and revenue, helping to mitigate risks and plan transitions.
-
Strategic Product Lifecycle Management
Utilizing competitive intelligence to optimize the timing of product launches, pricing strategies, and patent extensions for brand protection.
Strategic Insights for Managing Patent Expiry Risks with Nexdigm
Nexdigm offers strategic insights to help pharmaceutical companies effectively manage the risks associated with patent expiries. By leveraging advanced patent landscape analysis, competitive intelligence, and market forecasting, Nexdigm provides actionable data to anticipate generic competition and its financial impact. These insights enable companies to adjust their product lifecycle strategies, optimize R&D investments, and navigate market transitions, ultimately minimizing revenue loss and sustaining long-term growth.
Nexdigm’s Data-Driven Approach to Patent Expiry Forecasting
Nexdigm’s data-driven approach to patent expiry forecasting leverages advanced analytics and patent landscape analysis to predict upcoming expiries, assess market risks, and provide actionable insights, enabling pharma companies to make informed strategic decisions.
-
Market Impact Assessment Post-Patent Expiry
Evaluating the financial and market share impact of patent expiries, helping companies plan for generic competition and revenue shifts.
-
Risk Mitigation Strategies Based on Data Insights
Offering tailored strategies to mitigate risks related to patent expiries, leveraging data to protect revenue and market position.
-
Proactive Product Lifecycle Management
Optimizing product lifecycles using patent expiry forecasts, ensuring timely responses to market shifts and maximizing long-term profitability.
-
Integrating Regulatory Trends with Patent Expiry Forecasting
Combining patent expiry analysis with regulatory insights to develop comprehensive strategies for navigating legal and market challenges.
Nexdigm’s case:
Nexdigm supported a healthcare client with a competitive intelligence and market assessment engagement, resulting in 57% improvement in customer experience scores and a 12% increase in repeat engagements within three months, driven by structured data analysis and strategic insights. The project underscored how data‑driven research can refine market positioning and improve outcome metrics.
To take the next step, simply visit our Request a Consultation page and share your requirements with us.
Harsh Mittal
+91-8422857704